Authored by: Dr. Juan Chavez, MD and Dr. Lucia Mireles-Chavez, MD
Hyperbaric oxygen therapy for long COVID offers a promising solution for those struggling with lingering symptoms months after infection. By delivering pure oxygen in a pressurized chamber, this treatment aims to reduce inflammation, boost cellular repair, and restore energy levels addressing fatigue, brain fog, and shortness of breath that often persist with long COVID. Early studies and patient reports highlight significant improvements in cognitive function and overall quality of life, sometimes within just a few weeks of sessions.
Clinics specializing in hyperbaric medicine have seen encouraging results, with measurable symptom relief and improved daily functioning in many patients. With extensive research and clinical experience, experts are uncovering how this therapy accelerates recovery where traditional treatments fall short.
Long COVID symptoms affect millions globally, creating unique challenges for both patients and healthcare providers. Persistent health issues often remain for months after the initial SARS-CoV-2 infection, leading to varied diagnostic and treatment complexities.
Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC), covers symptoms that last beyond four weeks after initial infection. Fatigue, cognitive impairment, and respiratory problems commonly appear in these cases.
Patients suffering with post Covid 19 condition often report debilitating tiredness, limiting daily activities. Many experience traumatic brain injury or brain fog, characterized by memory issues and difficulty concentrating. Shortness of breath, palpitations, and muscle pain also persist after acute COVID-19 subsides. Symptoms present in individuals regardless of initial infection severity.
Medical providers face significant challenges when treating long COVID due to limited standardized protocols. Symptoms vary widely, making diagnosis complex and individualized treatment necessary.
The Centers for Disease Control and Prevention (CDC) notes ongoing research into long COVID, but clear biomarkers and definitive tests remain absent. Providers currently rely on patient history and symptom tracking to develop treatment plans. Multidisciplinary teams including pulmonologists, neurologists, and rehabilitation specialists often collaborate to address multiple concurrent issues.
Long COVID significantly reduces quality of life for many affected individuals, with chronic symptoms disrupting employment, relationships, and mental health. Surveys from organizations like the World Health Organization (WHO) report fatigue and cognitive dysfunction as leading causes of disability in these patients.
Extended absences from work or school are frequent, and ongoing health issues increase reliance on caregivers or specialized outpatient services. Emotional symptoms, such as anxiety and depression, frequently accompany physical complaints, compounding the difficulty of recovery.
Emerging research and patient advocacy groups highlight a strong need for new therapies to address long COVID symptoms. Existing treatment strategies focus on managing individual symptoms rather than reversing the underlying cause.
Medical offices and specialized clinics report increased appointments for long COVID evaluation and management, reflecting the growing recognition of persistent symptoms in clinical practice. Researchers continue clinical trials to evaluate innovative therapies, seeking solutions for patients without existing effective options.
Hyperbaric oxygen therapy for long COVID uses elevated atmospheric pressure and pure oxygen in a clinical chamber. This approach helps deliver more oxygen to body tissues, impacting inflammation and recovery pathways in patients with persistent post-COVID symptoms.
Hyperbaric oxygen treatment for long COVID involves sessions in a sealed chamber at two to three times normal atmospheric pressure. Patients breathe 100% oxygen during these visits, increasing plasma oxygen concentration throughout the body.
Increased oxygen delivery helps restore tissue function. Clinical settings carefully monitor each session, which typically lasts 60 to 90 minutes. Long COVID patients often require a series of sessions, with research noting that benefits accumulate over multiple treatments.
Rapid oxygen delivery counters tissue hypoxia associated with long COVID symptoms like fatigue and cognitive impairment. Controlled clinic conditions ensure patient safety and optimal dosing during the therapy process.
HBOT provides anti-inflammatory effects for long COVID by reducing cytokines linked to ongoing immune activity. Sessions decrease pro-inflammatory markers, including IL-1, IL-6, and TNF-α, while increasing anti-inflammatory cytokine IL-10 levels.
Treatment improves microvascular blood flow by protecting endothelial cells. This leads to better circulation, which can address the organ and neurological symptoms tied to long COVID. Enhanced oxygenation under pressure promotes capillary growth, supporting the repair of damaged tissues.
Other effects documented in medical studies include stimulation of neuroplasticity and immune modulation. These mechanisms can enhance cognitive function, decrease heart palpitations, and improve sleep quality reported in long COVID cases. Multimodal benefits have led experienced clinics to recommend HBOT for persistent post-viral syndromes.
Hyperbaric oxygen therapy for long COVID increases the amount of oxygen in the blood by providing 100% oxygen in a pressurized medical chamber. By delivering more oxygen under controlled clinical supervision, the therapy addresses underlying mechanisms contributing to persistent symptoms.
Hyperbaric oxygen therapy for long COVID promotes tissue healing through several targeted biological mechanisms. Anti-inflammatory responses occur when HBOT decreases pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α, while increasing anti-inflammatory cytokines like IL-10. This cytokine shift helps reduce systemic inflammation linked to many long COVID symptoms.
Vascular benefits result from improved endothelial function and increased nitric oxide bioavailability, which enhance microcirculation and help reverse tissue hypoxia. Enhanced oxygen delivery reduces oxidative stress and stimulates angiogenesis the formation of new blood vessels further supporting recovery from vascular and fatigue-related symptoms.
Neural repair forms another important HBOT mechanism in long COVID recovery. Patients experience stimulation of neuroplasticity, including synaptic growth and stem cell mobilization, as well as mitochondrial biogenesis. This mechanism addresses brain fog and other cognitive challenges frequently reported by post COVID condition patients. Additionally, the therapy modulates immune function by balancing overactive immune responses, potentially correcting immune dysregulation.
Patient reported outcome measures after medically supervised hyperbaric oxygen therapy for long COVID. Reductions in severe symptoms such as fatigue, pain, and cognitive dysfunction. Improvements in memory, attention, and information processing speed are noted in randomized controlled trials and clinical case studies.
Physical outcomes documented include enhanced lung function, reduced oxidative stress markers, and greater exercise capacity. HBOT also supports better sleep and lowers psychiatric symptoms like anxiety and depression issues commonly experienced by long COVID patients. Clinical observations and patient surveys confirm that many experience better daily functioning and quality of life following a course of therapy in specialty clinics.
Some individuals also note relief from heart palpitations, breathlessness, and persistent headaches. Physicians increasingly recommend hyperbaric oxygen therapy in controlled medical environments as a promising adjunctive treatment for long COVID due to its broad benefit spectrum.
Research on hyperbaric oxygen therapy for long COVID shows promising results, with ongoing clinical trials and case reports available. Results focus on symptom relief, improved function, and insights into underlying mechanisms.
Clinical trials on hyperbaric oxygen therapy for long COVID use randomized, double-blind designs. One Phase II trial administers up to 10 sessions at 240 kPa over six weeks, comparing to a sham group at 134 kPa. These studies assess efficacy and safety in a controlled medical office setting.
Results demonstrate significant improvements in fatigue, cognition, attention, sleep quality, and overall physical ability. Multiple reports indicate reductions in neuropsychiatric symptoms, including anxiety and depression, after a series of clinic-based sessions. Fatigue scores often drop, and cognitive test outcomes, such as attention tasks, improve measurably.
Additional evidence links these benefits to physiological processes. For example, hyperbaric oxygen therapy for long COVID reduces levels of pro-inflammatory cytokines like IL-1, IL-6, and TNF-α and raises anti-inflammatory mediators like IL-10. Researchers also note improved microvascular blood flow, reversing local tissue hypoxia and promoting cellular repair.
Clinical studies of hyperbaric oxygen therapy for long COVID remain small and preliminary. Many published results come from case reports or small cohorts, limiting broad generalizability. Larger, multicenter randomized controlled trials are still needed.
Protocols for hyperbaric oxygen therapy in long COVID, including pressure settings and session counts, aren't standardized yet. Heterogeneity among study designs makes comparisons challenging. Long-term safety and sustained outcomes require more extended follow-up and larger sample sizes.
Hyperbaric oxygen therapy for long COVID carries a strong safety profile in clinical settings, yet some risks and access limitations persist. Patients considering HBOT should understand the reported side effects and potential barriers to treatment.
Ear barotrauma ranks among the most reported side effects during hyperbaric oxygen therapy for long COVID. Some patients develop ear pain or, rarely, eardrum injury due to chamber pressurization. Sinus pain and nosebleeds may occur, especially in those with pre-existing sinus issues. Temporary vision changes, such as blurred vision, can follow multiple sessions, though these typically resolve. Cataract formation appears with long-term HBOT but is rarely associated with the short treatment regimens used for long COVID.
Short-term lung function decline has been observed, with risk increasing in individuals with chronic lung disease. Claustrophobia and anxiety sometimes affect those new to chamber treatment. Facilities use strict monitoring to rapidly address these events and reduce discomfort. Most side effects resolve shortly after session completion, while serious complications like seizures or lung collapse have only been reported in rare cases.
Candidates for hyperbaric oxygen therapy for long COVID usually present with symptoms persisting beyond 12 weeks. These symptoms include fatigue, cognitive changes, psychiatric issues, sleep disturbances, and chronic pain. Most patients undergo screening by multidisciplinary teams to confirm the diagnosis and ensure suitability for HBOT.
Certain medical conditions can increase risks during hyperbaric oxygen therapy for long COVID. Contraindications include untreated respiratory infections, active fever, uncontrolled asthma, and specific ear or eye diseases. Patients with advanced lung diseases may face greater risks and typically aren't eligible for this treatment. Providers assess eligibility individually, prioritizing safety.
FDA approval for hyperbaric oxygen therapy in long COVID hasn't been granted yet. The FDA has approved HBOT for other conditions, such as decompression sickness and chronic wounds. Patients accessing HBOT for long COVID participate in clinical trials or specialized protocols, following strict safety guidelines.
Access to hyperbaric oxygen therapy for long COVID depends on specialized medical facilities offering this service. These clinics provide certified staff and advanced chamber equipment to ensure safe, effective treatment. Costs remain substantial, often limiting availability, and insurance rarely covers this indication.
Some research proposes alternative delivery models to increase accessibility and affordability. However, medical guidelines require that patients complete HBOT within controlled, monitored clinical environments. Facilities prioritize protocol adherence and safety due to fire risks related to high-oxygen exposure. Scheduling and capacity limitations at certified centers currently restrict broader access, especially outside major cities.
Hyperbaric oxygen therapy for long COVID takes place in a medically supervised setting, supporting symptom improvement for patients with persistent cases. Understanding the therapy process and communicating with healthcare providers ensures a smoother experience and optimized outcomes.
Sessions of hyperbaric oxygen therapy for long COVID occur in a pressurized chamber, with patients breathing 100% oxygen at 2-3 times normal atmospheric pressure. Each session usually lasts around 90 minutes and involves complete monitoring by trained professionals. The chamber stays quiet, and patients remain in constant contact with staff for safety and comfort.
Patients receiving hyperbaric oxygen therapy for long COVID experience oxygen delivered directly to tissues, supporting reduced inflammation, improved oxygenation, and tissue repair. Most protocols involve daily sessions, often totaling 40 over 6-8 weeks, depending on medical assessment. Side effects are minimal, mainly including ear or sinus discomfort, which medical staff address promptly.
Hyperbaric oxygen therapy (HBOT) is a medical treatment in which patients breathe 100% pure oxygen in a pressurized chamber. This process boosts the amount of oxygen delivered to the body’s tissues, promoting healing, reducing inflammation, and aiding cellular repair.
Yes, early studies and patient experiences suggest HBOT can reduce long COVID symptoms like fatigue, brain fog, and shortness of breath. Many patients report improved cognitive function, energy levels, and overall quality of life after a series of sessions.
HBOT involves inhaling pure oxygen at increased atmospheric pressure, which helps deliver more oxygen to damaged tissues. This can reduce inflammation, enhance blood flow, and support tissue and nerve healing, potentially easing long COVID symptoms.
HBOT is often used to target symptoms such as persistent fatigue, cognitive impairment (brain fog), shortness of breath, sleep disturbances, and chest pain. Patients may also notice improvements in mood and daily functioning.
HBOT is generally safe when performed in specialized clinics under medical supervision. Common side effects include mild ear or sinus discomfort and temporary vision changes. Serious complications are rare but can include lung or ear injuries.
HBOT is usually considered for patients with long COVID symptoms that persist beyond 12 weeks after initial infection, especially when traditional treatments have not provided relief. A careful medical evaluation is needed to rule out contraindications.
Most side effects are minor, such as pressure in the ears, sinus pain, or temporary changes in vision. Serious risks are uncommon but may include lung barotrauma or oxygen toxicity. Always consult a healthcare provider before starting treatment.
Hyperbaric oxygen therapy is gaining attention as a promising option for those struggling with long COVID symptoms that disrupt daily life. As research continues and more clinics adopt this approach patients and providers are watching closely for new developments.
Anyone considering HBOT should weigh the potential benefits and risks with their healthcare team and stay informed about emerging evidence. With ongoing studies and evolving protocols the landscape for long COVID care is changing offering hope for improved quality of life and recovery for many.
Supercharge Your Healing. Enhance Immunity. Speed Recovery.
Imagine breathing 100% pure oxygen while relaxing in a pressurized chamber that delivers up to triple the oxygen your body normally gets. That's the power of Hyperbaric Oxygen Therapy (HBOT). A proven medical treatment that floods your cells with the oxygen they crave for rapid healing and recovery.
This isn't just oxygen therapy. Our medical-grade pressurized chamber increases atmospheric pressure by 1.5 to 3 times normal levels, allowing your lungs to absorb dramatically more oxygen than ever before. This oxygen-rich plasma then travels throughout your body, accelerating healing, fighting infection, and regenerating damaged tissue.
Why settle for slow healing when you can supercharge it? HBOT is FDA-approved for multiple conditions and backed by studies in the Journal of Wound Care showing how oxygen kickstarts your body's natural healing phases. Professional athletes use it for recovery. Medical centers worldwide depend on it for serious conditions.
At Las Vegas Medical Institute, we combine advanced hyperbaric technology with deep medical expertise for healing that speaks for itself.
Schedule Your Hyperbaric Oxygen Therapy Consultation here, or call us today at (702) 577-3174 to discover how HBOT is revolutionizing recovery across Las Vegas!
Cover Image Credit: LiudmilaChernetska / 123RF.com (Licensed). Photo Illustration by: By Las Vegas Medical Institute.
Red light therapy for skin is a safe non-invasive treatment that uses low-wavelength red light to improve skin tone, reduce wrinkles, and speed up healing. People turn to red light therapy to boost collagen, fade scars, and calm inflammation often seeing noticeable improvements in just a few weeks. This gentle approach works for all skin…
Oxygen therapy for pneumonia is the fastest and most effective way to boost blood oxygen levels when lungs can’t absorb enough on their own. Doctors use oxygen therapy to help patients breathe easier, prevent dangerous drops in oxygen, and speed up recovery from pneumonia, with the healthcare provider playing a crucial role in selecting and…
Red light therapy for eyes is a non-invasive treatment that uses low-level red and near-infrared light to support eye health and improve vision. Research shows that red light treatment can help reduce eye strain, slow age-related decline, and even enhance retinal function with just a few minutes of exposure each day. Many users turn to…
Before and after hyperbaric oxygen therapy, patients often notice dramatic improvements in healing, energy, and overall well-being. Hyperbaric oxygen therapy (HBOT) delivers pure oxygen in a pressurized chamber, helping the body repair tissue, fight infection, and reduce inflammation. Many people seek HBOT to speed up recovery from injuries, manage chronic conditions, or enhance post-surgery results.The…
